LOXIGLUMIDE
| Title | Journal |
|---|---|
| Stimulatory effect of N-methyltyramine, a congener of beer, on pancreatic secretion in conscious rats. | Alcoholism, clinical and experimental research 20100201 |
| The effects on diet, anastomotic type, and loxiglumide on gastric emptying following gastrojejunostomy. | International journal of surgery (London, England) 20090401 |
| Cholecystokinin hyperresponsiveness in functional dyspepsia. | World journal of gastroenterology 20060507 |
| Anthranilic acid based CCK1 receptor antagonists and CCK-8 have a common step in their 'receptor desmodynamic processes'. | Journal of medicinal chemistry 20060420 |
| Effects of the cholecystokinin A receptor antagonist loxiglumide on the proliferation and cell cycle time of pancreatic acinar cells in rats. | Pancreas 20060301 |
| Role of cholecystokinin in appetite control and body weight regulation. | Obesity reviews : an official journal of the International Association for the Study of Obesity 20051101 |
| [New aspects of pharmaco-therapy for acute pancreatitis]. | Nihon rinsho. Japanese journal of clinical medicine 20041101 |
| Use of a hepta-Tyr antibiotic modified silica stationary phase for the enantiomeric resolution of D,L-loxiglumide by electrochromatography and nano-liquid chromatography. | Journal of chromatography. A 20041008 |
| Involvement of capsaicin-sensitive afferent nerves and cholecystokinin 2/gastrin receptors in gastroprotection and adaptation of gastric mucosa to Helicobacter pylori-lipopolysaccharide. | The Journal of pharmacology and experimental therapeutics 20040701 |
| Long-term bile diversion enhances basal and duodenal oleate-stimulated pancreatic exocrine secretion in dogs. | The Tohoku journal of experimental medicine 20040601 |
| Sensitive SPE-HPLC method to determine a novel angiotensin-AT1 antagonist in biological samples. | Journal of pharmaceutical and biomedical analysis 20040416 |
| The effects of an essential fatty acid compound and a cholecystokinin-8 antagonist on iron deficiency induced anorexia and learning deficits. | Nutritional neuroscience 20040401 |
| Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats. | American journal of physiology. Gastrointestinal and liver physiology 20031001 |
| CCK-1 receptor blockade for treatment of biliary colic: a pilot study. | Alimentary pharmacology & therapeutics 20030801 |
| Effect of cholecystokinin1 receptor antagonist loxiglumide (CR1505) on basal pancreatic exocrine secretion in conscious rats. | Pancreas 20030101 |
| Role of CCK(A) receptors in postprandial lower esophageal sphincter function in morbidly obese subjects. | Digestive diseases and sciences 20021101 |
| Effect of cholecystokinin-A receptor blockade on postprandial insulinaemia and gastric emptying in humans. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20021001 |
| Clinical evaluation of oral administration of a cholecystokinin-A receptor antagonist (loxiglumide) to patients with acute, painful attacks of chronic pancreatitis: a multicenter dose-response study in Japan. | Pancreas 20020701 |
| Inhibitory effect of loxiglumide (CR 1505), a cholecystokinin receptor antagonist, on N-nitrosobis(2-oxopropyl) amine-induced biliary carcinogenesis in Syrian hamsters. | World journal of surgery 20020301 |
| Transient lower oesophageal sphincter relaxations--a pharmacological target for gastro-oesophageal reflux disease? | Alimentary pharmacology & therapeutics 20020101 |
| The effect of cholecystokinin antagonism on postprandial lower oesophageal sphincter function in asymptomatic volunteers and patients with reflux disease. | Alimentary pharmacology & therapeutics 20010901 |
| Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans. | American journal of physiology. Regulatory, integrative and comparative physiology 20010401 |
| Role of cholecystokinin in the intestinal phase of pancreatic circulation in dogs. | American journal of physiology. Gastrointestinal and liver physiology 20010401 |
| Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on gastric motility in duodenal ulcer patients. | Scandinavian journal of gastroenterology 20010301 |
| Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves. | Regulatory peptides 19990630 |
| Involvement of endogenous cholecystokinin and somatostatin in gastroprotection induced by intraduodenal fat. | Journal of clinical gastroenterology 19980101 |
| Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro. | European journal of pharmacology 19960523 |
| Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist. | British journal of pharmacology 19960401 |
| Pharmacological profile of FK480, a novel cholecystokinin type-A receptor antagonist: comparison to loxiglumide. | The Journal of pharmacology and experimental therapeutics 19940201 |
| Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist. | Arzneimittel-Forschung 19870601 |